Literature DB >> 12379690

Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.

Kevan L Hartshorn1, Mitchell R White, Erika C Crouch.   

Abstract

Collectins play important roles in host defense against infectious microorganisms. We now demonstrate that the serum collectins mannose-binding lectin (MBL) and conglutinin have less ability to bind to, aggregate, and enhance neutrophil uptake of several strains of gram-negative and gram-positive bacteria than pulmonary surfactant protein D (SP-D). Collectins are composed of four major structural domains (i.e., N-terminal, collagen, and neck and carbohydrate recognition domains). To determine which domains of SP-D are responsible for its greater bacterial binding or aggregating activity, activities of chimeric collectins containing the N-terminal and collagen domains of SP-D coupled to the neck recognition domains and carbohydrate recognition domains (CRD) of MBL or conglutinin (SP-D/Cong(neck+CRD) and SP-D/MBL(neck+CRD)) were tested. The SP-D/Cong(neck+CRD) and SP-D/MBL(neck+CRD) chimeras bound to and aggregated the bacteria more strongly than did wild-type MBL or conglutinin. SP-D/MBL(neck+CRD) also enhanced neutrophil uptake of bacteria more so than MBL. Hence, the SP-D N-terminal and/or collagen domains contribute to the enhanced bacterial binding and aggregating activities of SP-D. In prior studies, SP-D/Cong(neck+CRD) and SP-D/MBL(neck+CRD) had increased ability to bind to influenza virus compared not only with that of conglutinin or MBL but with that of wild-type SP-D as well. In contrast, the chimeras had either reduced or unchanged ability to bind to or aggregate bacteria compared to that of wild-type SP-D. Hence, although replacement of the neck recognition domains and CRDs of SP-D with those of MBL and conglutinin conferred increased viral binding activity, it did not favorably affect bacterial binding activity, suggesting that requirements for optimal collectin binding to influenza virus and bacteria differ.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379690      PMCID: PMC130308          DOI: 10.1128/IAI.70.11.6129-6139.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Human mannose-binding protein functions as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; M R White; E M Anders; M Super; R A Ezekowitz; A I Tauber
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

2.  Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion.

Authors:  P Brown-Augsburger; D Chang; K Rust; E C Crouch
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

3.  The role of the amino-terminal domain and the collagenous region in the structure and the function of rat surfactant protein D.

Authors:  Y Ogasawara; D R Voelker
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

4.  Mannan-binding protein and bovine conglutinin mediate enhancement of herpes simplex virus type 2 infection in mice.

Authors:  P B Fischer; S Ellermann-Eriksen; S Thiel; J C Jensenius; S C Mogensen
Journal:  Scand J Immunol       Date:  1994-05       Impact factor: 3.487

5.  Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly.

Authors:  E Crouch; D Chang; K Rust; A Persson; J Heuser
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

6.  Bovine conglutinin gene exon structure reveals its evolutionary relationship to surfactant protein-D.

Authors:  L S Liou; R Sastry; K L Hartshorn; Y M Lee; T B Okarma; A I Tauber; K N Sastry
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

7.  Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.

Authors:  K L Hartshorn; E C Crouch; M R White; P Eggleton; A I Tauber; D Chang; K Sastry
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Differential recognition by conglutinin and mannan-binding protein of N-glycans presented on neoglycolipids and glycoproteins with special reference to complement glycoprotein C3 and ribonuclease B.

Authors:  D Solís; T Feizi; C T Yuen; A M Lawson; R A Harrison; R W Loveless
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

9.  Distinct and overlapping functions of allelic forms of human mannose binding protein.

Authors:  M Super; S D Gillies; S Foley; K Sastry; J E Schweinle; V J Silverman; R A Ezekowitz
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

10.  Conglutinin acts as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; D Brown; M R White; T B Okarma; Y M Lee; A I Tauber
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

View more
  16 in total

Review 1.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

Review 2.  S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation.

Authors:  Elena N Atochina-Vasserman
Journal:  Biochim Biophys Acta       Date:  2011-12-13

3.  Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation.

Authors:  Kevan L Hartshorn; Antoon Ligtenberg; Mitchell R White; Martin Van Eijk; Max Hartshorn; Lily Pemberton; Uffe Holmskov; Erika Crouch
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

4.  Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens.

Authors:  Soren Hansen; Bernice Lo; Kathy Evans; Pavlos Neophytou; Uffe Holmskov; Jo Rae Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-10       Impact factor: 6.914

5.  Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions.

Authors:  Luanne Hall-Stoodley; Gayle Watts; Joy E Crowther; Ashwin Balagopal; Jordi B Torrelles; James Robison-Cox; Robert F Bargatze; Allen G Harmsen; Erika C Crouch; Larry S Schlesinger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities.

Authors:  Lyndsay M Schaeffer; Francis X McCormack; Huixing Wu; Alison A Weiss
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 7.  Nitrosothiols in the immune system: signaling and protection.

Authors:  Pablo Hernansanz-Agustín; Alicia Izquierdo-Álvarez; Almudena García-Ortiz; Sales Ibiza; Juan M Serrador; Antonio Martínez-Ruiz
Journal:  Antioxid Redox Signal       Date:  2012-08-17       Impact factor: 8.401

8.  Targeting an antimicrobial effector function in insect immunity as a pest control strategy.

Authors:  Mark S Bulmer; Ido Bachelet; Rahul Raman; Rebeca B Rosengaus; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-08       Impact factor: 11.205

9.  Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils.

Authors:  Rania Jounblat; Aras Kadioglu; Francesco Iannelli; Gianni Pozzi; Paul Eggleton; Peter W Andrew
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Surfactant protein D inhibits TNF-alpha production by macrophages and dendritic cells in mice.

Authors:  László Hortobágyi; Sonja Kierstein; Kateryna Krytska; Xiaoping Zhu; Anuk M Das; Francis Poulain; Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2008-06-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.